Founded in 1964, DIA (the Drug Information Association) is an international, nonprofit, multidisciplinary association that fosters innovation for improved health and well-being worldwide. DIA provides international professionals a neutral and transparent forum for the exchange of ideas and collaboration to improve health globally through the advancement of life-saving medicines and technologies. DIA offers knowledge resources and forums on product development, regulatory science, and therapeutic innovation for professionals in the pharmaceutical, biotechnology, and medical device communities.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

SUN PHARMA & ICGEB ANNOUNCE NEW EXCLUSIVE COLLABORATION TO DEVELOP NOVEL DENGUE VACCINE FOR INDIA & GLOBAL MARKETS

SUN PHARMA | October 19, 2016

news image

International Centre for Genetic Engineering and Biotechnology (ICGEB) and Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) today announced their new collaboration for development of a dengue vaccine, targeted against all the four serotypes of Dengue virus that cause disease in humans....

Read More

A UK PHARMACEUTICAL COMPANY TAKES DRUG PRICE HIKING TO NEW HEIGHTS OF CRUELTY

Canary Media | December 16, 2016

news image

The Competition and Markets Authority (CMA) has accused UK pharmaceutical company Actavis of jacking up the price of a life-saving drug by 12,000%....

Read More

CONTROVERSIAL 'PHARMA BRO' SHKRELI SAYS 'OF COURSE' HE'D RAISE DRUG PRICE AGAIN

Chicago Tribune Media Group | December 23, 2016

news image

Outspoken former pharmaceutical executive Martin Shkreli said the national outrage over drug pricing was blown out of proportion and heightened by the U.S. presidential election, although he conceded he could have predicted the criticism better....

Read More

TRUMP TAKES AIM AT DRUG COMPANIES: 'I DON'T LIKE WHAT HAS HAPPENED WITH DRUG PRICES'

Chicago Tribune Media Group | December 08, 2016

news image

Biotech and pharmaceutical stocks rose after the November election, reflecting investor optimism that a Trump presidency would mean less focus on drug prices....

Read More
news image

SUN PHARMA & ICGEB ANNOUNCE NEW EXCLUSIVE COLLABORATION TO DEVELOP NOVEL DENGUE VACCINE FOR INDIA & GLOBAL MARKETS

SUN PHARMA | October 19, 2016

International Centre for Genetic Engineering and Biotechnology (ICGEB) and Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) today announced their new collaboration for development of a dengue vaccine, targeted against all the four serotypes of Dengue virus that cause disease in humans....

Read More
news image

A UK PHARMACEUTICAL COMPANY TAKES DRUG PRICE HIKING TO NEW HEIGHTS OF CRUELTY

Canary Media | December 16, 2016

The Competition and Markets Authority (CMA) has accused UK pharmaceutical company Actavis of jacking up the price of a life-saving drug by 12,000%....

Read More
news image

CONTROVERSIAL 'PHARMA BRO' SHKRELI SAYS 'OF COURSE' HE'D RAISE DRUG PRICE AGAIN

Chicago Tribune Media Group | December 23, 2016

Outspoken former pharmaceutical executive Martin Shkreli said the national outrage over drug pricing was blown out of proportion and heightened by the U.S. presidential election, although he conceded he could have predicted the criticism better....

Read More
news image

TRUMP TAKES AIM AT DRUG COMPANIES: 'I DON'T LIKE WHAT HAS HAPPENED WITH DRUG PRICES'

Chicago Tribune Media Group | December 08, 2016

Biotech and pharmaceutical stocks rose after the November election, reflecting investor optimism that a Trump presidency would mean less focus on drug prices....

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us